Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Lots of good gouge in this article.

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on Aug 27, 2024 4:24pm

116 Views

Post# 36198342

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lots of good gouge in this article.

There is also a Pre IND for a 505 (b)(2) application that you submit to the FDA first. And yes, the ANDA application is for Epidiolex, but as a new indication and for guidance for the drug Epidiolex, which is already approved. The active ingredient CBD is the same in both. Just don't give up

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?